Unless this is a nice tactic to get a certain company or two to step up their offer knowing that the company now has the resources to go it alone and reap all the rewards, assuming Lympro is as good as advertised.
Regardless, the company is continuing to expand in their brain trust and that's a good thing. Now, let's just get some significant news that helps lift the pps so that the company can uplist. I have always said that the company will never get full recognition if it lingers on the OTC.